For outpatient Medicare beneficiaries, MIPS-eligible clinicians and groups must attest to having: For the first performance year, at least 60 percent of medical records with documentation of screening patients for abnormal blood glucose, referring eligible patients with prediabetes to a CDC-recognized diabetes prevention program, and developing individualized glycemic treatment plans that: a) Consider patient-specific factors, including, at least 1) age, 2) comorbidities, and 3) risk for hypoglycemia, and b) Are reassessed at least annually. The performance threshold will increase to 75 percent for the second performance year and onward. Clinicians must attest that 60 percent (for the first year) and 75 percent (for the second year and beyond) of their medical records include documentation of screening patients for abnormal blood glucose according to current US Preventive Services Task Force (USPSTF) and/or American Diabetes Association (ADA) guidelines. Clinicians must attest that 60 percent (for the first year) and 75 percent (for the second year and beyond) of their medical records include documentation of referring eligible patients with prediabetes to a CDC-recognized diabetes prevention program operating under the framework of the National Diabetes Prevention Program. Clinicians must attest that 60 percent (for the first year) and 75 percent (for the second year and beyond) of their medical records document individualized glycemic treatment plans representing patients who are being seen for at least 90 days during the performance period.